ANI Pharmaceuticals, Inc. (ANIP)
80.06
+0.58
(+0.74%)
USD |
NASDAQ |
Apr 08, 12:54
ANI Pharmaceuticals Cash from Investing (TTM) : -34.32M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Liquidia Corp. | -6.336M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Indivior Pharmaceuticals, Inc. | -66.60M |
| Replimune Group, Inc. | 216.64M |
| ADMA Biologics, Inc. | -21.89M |